Evaluation of ROS1 Expression in a Large Cohort of Early Stage Lung Cancer

被引：0
|
作者：
Dyrbekk, A. P. [1 ]
Warsame, A. [2 ]
Lund-Iversen, M. [2 ]
Suhrke, P. [1 ]
Helland, A. [3 ,4 ]
Brustugun, O. T. [5 ]
机构：
[1] Vestfold Hosp Trust, Pathol Dept, Tonsberg, Norway
[2] Oslo Univ Hosp, Dept Pathol, Oslo, Norway
[3] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[4] Oslo Univ Hosp, Inst Canc Res, Oslo, Norway
[5] Vestre Viken Hosp Trust, Drammen Hosp, Sect Oncol, Drammen, Norway
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
molecular pathology; ROS-1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P59.18
引用
收藏
页码：S1155 / S1156
页数：2
相关论文
共 50 条
  • [31] Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma
    Grenier, Karl
    Riviere, Jean-Baptiste
    Bencheikh, Bouchra Ouled Amar
    Corredor, Andrea Liliam Gomez
    Shieh, Benjamin Christopher
    Wang, Hangjun
    Fiset, Pierre Olivier
    Camilleri-Broet, Sophie
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (07):
  • [32] New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)
    Russo, Alessandro
    Lopes, Ana Rita
    McCusker, Michael G.
    Garrigues, Sandra Gimenez
    Ricciardi, Giuseppina R.
    Arensmeyer, Katherine E.
    Scilla, Katherine A.
    Mehra, Ranee
    Rolfo, Christian
    CURRENT ONCOLOGY REPORTS, 2020, 22 (05)
  • [33] Comparison of Methods in the Detection of ALK and ROS1 Rearrangements in Lung Cancer
    Rogers, Toni-Maree
    Russell, Prudence A.
    Wright, Gavin
    Wainer, Zoe
    Pang, Jia-Min
    Henricksen, Leigh A.
    Singh, Shalini
    Stanislaw, Stacey
    Grille, James
    Roberts, Esteban
    Solomon, Benjamin
    Fox, Stephen B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (04) : 611 - 618
  • [34] ALK and ROS1 Testing on Lung Cancer Cytologic Samples: Perspectives
    Pisapia, Pasquale
    Lozano, Maria D.
    Vigliar, Elena
    Bellevicine, Claudio
    Pepe, Francesco
    Malapelle, Umberto
    Troncone, Giancarlo
    CANCER CYTOPATHOLOGY, 2017, 125 (11) : 817 - 830
  • [35] ALK and ROS1 as a joint target for the treatment of lung cancer: a review
    Puig de la Bellacasa, Raimon
    Karachaliou, Niki
    Estrada-Tejedor, Roger
    Teixido, Jordi
    Costa, Carlota
    Borrell, Jose I.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (02) : 72 - 86
  • [36] New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)
    Alessandro Russo
    Ana Rita Lopes
    Michael G. McCusker
    Sandra Gimenez Garrigues
    Giuseppina R. Ricciardi
    Katherine E. Arensmeyer
    Katherine A. Scilla
    Ranee Mehra
    Christian Rolfo
    Current Oncology Reports, 2020, 22
  • [37] Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
    Furugaki, Koh
    Mochizuki, Marie
    Kohno, Mirei
    Shu, Sei
    Harada, Naoki
    Yoshimura, Yasushi
    BMC CANCER, 2019, 19 (1)
  • [38] Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
    Koh Furugaki
    Marie Mochizuki
    Mirei Kohno
    Sei Shu
    Naoki Harada
    Yasushi Yoshimura
    BMC Cancer, 19
  • [39] ROS1 Rearrangement in Thyroid Cancer
    Ritterhouse, Lauren L.
    Wirth, Lori J.
    Randolph, Gregory W.
    Sadow, Peter M.
    Ross, Douglas S.
    Liddy, Whitney
    Lennerz, Jochen K.
    THYROID, 2016, 26 (06) : 794 - 797
  • [40] ROS1 fusions in cancer: a review
    Uguen, Arnaud
    De Braekeleer, Marc
    FUTURE ONCOLOGY, 2016, 12 (16) : 1911 - 1928
12345